The Natsimbio holding company, which is part of the Rostec state corporation, has completed the first stage of influenza vaccine deliveries, surpassing expectations by delivering 21.2 million doses to regions across Russia ahead of schedule. This delivery is part of a larger plan that aims to distribute over 70 million doses of vaccines across the country throughout the year.
The received vaccines include 7 million doses of the Sovigripp drug, 4.5 million doses of Flu-M, and 9.7 million doses of the Ultrix Quadri vaccine. All deliveries have been completed one week ahead of schedule, enabling medical personnel to better prepare for the vaccination of the population. All vaccines are produced in Russia using full-cycle technology and contain the latest virus strains for the new epidemic season.
